Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples

In a prospective study, Craig Cohen and colleagues investigate the association between bacterial vaginosis and the risk of female-to-male HIV-1 transmission.

[1]  H. Lochs,et al.  Adherent Biofilms in Bacterial Vaginosis , 2005, Obstetrics and gynecology.

[2]  Gregor Reid,et al.  Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. , 2006, Microbes and infection.

[3]  King K. Holmes,et al.  Diagnostic Criteria and Microbial and Epidemiologic Associations , 1983 .

[4]  Ronald H Gray,et al.  Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial , 1999, The Lancet.

[5]  Detection of HIV DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya , 1994, JAMA.

[6]  R. Lindsay,et al.  Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis , 1997, The Lancet.

[7]  R. Greenblatt,et al.  Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). , 1999, Sexually transmitted diseases.

[8]  S. Shott,et al.  Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. , 2001, The Journal of infectious diseases.

[9]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[10]  H. Lochs,et al.  An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. , 2008, American journal of obstetrics and gynecology.

[11]  C. Cohen,et al.  Probiotics: The Potential for a Live Microbicide to Prevent HIV , 2011, Journal of acquired immune deficiency syndromes.

[12]  K. Holmes,et al.  P3.172 Bacterial vaginosis: risk factors among kenyan women and their male partners , 2006, Sexually Transmitted Infections.

[13]  Mei-Cheng Wang,et al.  The Short-term Variability of Bacterial Vaginosis Diagnosed by Nugent Gram Stain Criteria Among Sexually Active Women in Rakai, Uganda , 2011, Sexually transmitted diseases.

[14]  G. Reid,et al.  Probiotic strategies for the treatment and prevention of bacterial vaginosis , 2010, Expert opinion on pharmacotherapy.

[15]  R D Moore,et al.  Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. , 2000, JAMA.

[16]  James P. Hughes,et al.  Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. , 2010, The New England journal of medicine.

[17]  J. Schwebke,et al.  An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  G. Spear,et al.  Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. , 2000, The Journal of infectious diseases.

[19]  A. Caliendo,et al.  Detection of Fastidious Vaginal Bacteria in Women with HIV Infection and Bacterial Vaginosis , 2009, Infectious diseases in obstetrics and gynecology.

[20]  J. Overbaugh,et al.  Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding , 2007, AIDS.

[21]  J. Mullins,et al.  Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission , 2011, Science Translational Medicine.

[22]  R. Kaul,et al.  Bacterial Vaginosis in HIV-Infected Women Induces Reversible Alterations in the Cervical Immune Environment , 2008, Journal of acquired immune deficiency syndromes.

[23]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[24]  J. Baeten,et al.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. , 2008, The Journal of infectious diseases.

[25]  Maliha Aziz,et al.  The Effects of Circumcision on the Penis Microbiome , 2010, PloS one.

[26]  A. Caliendo,et al.  Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Hayes,et al.  Correlates of HIV-1 Genital Shedding in Tanzanian Women , 2011, PloS one.

[28]  J. Baeten,et al.  Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial , 2010, The Lancet.

[29]  S. Moses,et al.  HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. , 2006, American journal of clinical pathology.

[30]  R. Brunham,et al.  Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? , 1999, AIDS.

[31]  Mardge H. Cohen,et al.  Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. , 2005, The Journal of infectious diseases.

[32]  N. Sewankambo,et al.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis , 1997, The Lancet.

[33]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[34]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[35]  A. van der Straten,et al.  Probiotics: Potential to Prevent HIV and Sexually Transmitted Infections in Women , 2008, Sexually transmitted diseases.

[36]  Jun Zhang,et al.  Vulvovaginal Symptoms in Women With Bacterial Vaginosis , 2004, Obstetrics and gynecology.

[37]  D. Eschenbach.  History and review of bacterial vaginosis. , 1993, American journal of obstetrics and gynecology.

[38]  J. Baeten,et al.  Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. , 2008, The Journal of infectious diseases.

[39]  Michael Thrusfield,et al.  Statistics in epidemiology: methods, techniques, and applications , 1997 .

[40]  S. Shiboski,et al.  Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis , 2010, Sexually transmitted diseases.

[41]  N. Sewankambo,et al.  The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. , 2009, American journal of obstetrics and gynecology.

[42]  Connie Celum,et al.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis , 2010, The Lancet.

[43]  R. Nguti,et al.  Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts , 2007, AIDS.

[44]  J. Mullins,et al.  Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial , 2011, PloS one.

[45]  L. Peterson.  Bad bugs, no drugs: no ESCAPE revisited. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  M. de Jong,et al.  Human immunodeficiency virus‐1 acquisition in genital mucosa: Langerhans cells as key‐players , 2009, Journal of internal medicine.

[47]  R. McClelland,et al.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. , 2001, The Journal of infectious diseases.

[48]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[49]  A. Adimora,et al.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies , 2008, AIDS.

[50]  K. Holmes,et al.  Topical Penile Microbicide Use by Men to Prevent Recurrent Bacterial Vaginosis in Sex Partners: A Randomized Clinical Trial , 2011, Sexually transmitted diseases.

[51]  S. Garland,et al.  Prevalence of Gardnerella vaginalis and Atopobium vaginae in Virginal Women , 2006, Sexually transmitted diseases.

[52]  M. Vaneechoutte,et al.  The epidemiology of bacterial vaginosis in relation to sexual behaviour , 2010, BMC infectious diseases.

[53]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.